Mandate November 10, 2026 Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq…
Mandate June 29, 2026 Vinge advises Ambea on the public offer for Humana Ambea AB (publ) has made a public offer for all shares in Humana AB. The offer values all shares in…